Medexus Pharmaceuticals
Earnings Date & Report
Last updated:
Medexus Pharmaceuticals’s last earnings date was on 20 Sep 2024.
Medexus Pharmaceuticals stock Earnings report, Estimates & History
| 2020-02-19 | -0.08 | -0.04 |
|---|---|---|
| 2020-06-22 | -0.09 | -0.15 |
| 2020-08-11 | -0.02538 | -0.33 |
| 2021-03-01 | -0.03746 | -1.18 |
| 2021-06-16 | -0.02008 | -0.8 |
| 2021-08-16 | -0.04026 | -0.63 |
| 2021-11-10 | -0.26 | -0.32 |
| 2022-02-09 | -0.29 | -0.17 |
| 2022-06-22 | -0.22 | -0.27 |
| 2022-08-08 | -0.14 | -0.18 |
| 2022-11-08 | -0.14 | -0.14 |
| 2023-02-08 | -0.08 | -0.07 |
| 2023-06-21 | -0.05 | 0.34 |
| 2023-08-09 | 0.00667 | 0.03 |
| 2023-11-09 | -0.0117 | -0.05 |
| 2024-02-07 | -0.00773 | -0.02 |
| 2024-06-25 | 0.00857 | 0.03 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Medexus Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 20 Sep 2024 | N/A | N/A | N/A | N/A | N/A | |
| 25 Jun 2024 | Beat | $0.01 | $0.03 | N/A | N/A | |
| 17 Apr 2024 | N/A | N/A | N/A | N/A | N/A | |
| 7 Feb 2024 | Missed | -$0.01 | -$0.02 | 36.59M | 25.21M | |
| 9 Nov 2023 | Missed | -$0.01 | -$0.05 | N/A | 30.32M | |
| 9 Aug 2023 | Beat | $0.01 | $0.03 | N/A | 31.55M | |
| 21 Jun 2023 | Beat | -$0.05 | $0.34 | N/A | 28.63M | |
| 8 Feb 2023 | Beat | -$0.08 | -$0.07 | N/A | 28.73M | |
| 8 Nov 2022 | Matched | -$0.14 | -$0.14 | N/A | 27.68M | |
| 8 Aug 2022 | Missed | -$0.14 | -$0.18 | N/A | 23.04M | |
| 22 Jun 2022 | Missed | -$0.22 | -$0.27 | 41.67M | 20.26M | |
| 9 Feb 2022 | Beat | -$0.29 | -$0.17 | N/A | 21.27M | |
| 10 Nov 2021 | Missed | -$0.26 | -$0.32 | N/A | 17.90M | |
| 16 Aug 2021 | Missed | -$0.04 | -$0.63 | N/A | 17.26M | |
| 16 Jun 2021 | Missed | -$0.02 | -$0.8 | N/A | 79.66M | |
| 1 Mar 2021 | Missed | -$0.04 | -$1.18 | N/A | 24.71M | |
| 16 Nov 2020 | N/A | N/A | -$0.1 | N/A | 17.65M | |
| 11 Aug 2020 | Missed | -$0.03 | -$0.33 | N/A | 20.14M | |
| 22 Jun 2020 | Missed | -$0.09 | -$0.15 | N/A | 52.43M | |
| 19 Feb 2020 | Beat | -$0.08 | -$0.04 | N/A | 12.40M | |
Medexus Pharmaceuticals Earnings report FAQs
When is Medexus Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Medexus Pharmaceuticals's earnings date was on 9 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.